Related Experiment Video

Updated: Oct 23, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Chronic respiratory failure of infancy and childhood: clinical outcomes based on underlying etiology

W B Wheeler1, E L Maguire, S C Kurachek

  • 1Division of Pulmonary and Critical Care Medicine, Minneapolis Children's Medical Center, Minnesota.

Pediatric Pulmonology
|January 1, 1994
PubMed

Insights

Outcomes for pediatric chronic respiratory failure patients vary by diagnosis. Chronic lung disease patients showed better outcomes than those with neurologic or congenital conditions, despite higher rates of specific morbidities.

Area of Science:

  • Pediatric Pulmonology
  • Critical Care Medicine
  • Neonatology

Background:

  • Chronic respiratory failure of infancy and childhood (CRFIC) presents diverse clinical challenges.
  • Understanding how underlying diagnoses impact patient outcomes is crucial for effective management.

Purpose of the Study:

  • To evaluate the influence of underlying diagnosis on morbidity and mortality in pediatric patients with chronic respiratory failure.
  • To compare outcomes among patients with chronic lung disease (CLD), neurologic/neuromuscular diseases (NM), and congenital abnormalities (CA).

Main Methods:

  • A cohort of 55 pediatric patients with CRFIC was studied.
  • Patients were categorized into CLD, NM, or CA groups.
  • Outcomes including mortality, ventilatory support duration, tracheostomy, weaning success, neurodevelopment, and specific morbidities were assessed over a mean follow-up of 21.3 months.

Main Results:

  • Overall mortality was low (7%) with no significant differences between diagnostic groups.
  • Patients with CLD demonstrated superior outcomes in ventilatory support duration, tracheostomy duration, and weaning success compared to NM and CA groups.
  • CLD patients experienced higher frequencies of tracheomalacia, feeding disorders, and hypogammaglobulinemia G.

Conclusions:

  • Survival rates for pediatric chronic respiratory failure are high across different underlying diagnoses.
  • Morbidity profiles and treatment requirements significantly differ based on the etiology of chronic respiratory failure in children.
  • Chronic lung disease in pediatric patients with respiratory failure is associated with better long-term functional outcomes despite specific associated morbidities.

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...